Will a pre-therapy exercise intervention improve the outcomes of patients with advanced oesophageal cancer? World Cancer Research Fund (WCRF) has announced it’s 2023 research grants and we are delighted that our cancer research team at the University of Surrey was successful in securing a large grant to investigate whether a pre-therapy exercise intervention improve the […]
Exercise and outcomes in advanced oesophageal cancer Read More »
Harnessing the power of bacteria and viruses Our Targeted Cancer Therapy Group at the University of Surrey is researching a new ground-breaking research project and clinical trial to transform the treatment of bladder cancer. This will be our big fundraising appeal for 2018. So, please help raise the money to support this ground-breaking research. Around
Immunotherapy for Bladder Cancer Read More »
Upregulation of Innate Immunity in the tumour microenvironment of Oesophageal Cancer using an oncolytic virus in combination with immunotherapy Oesophageal cancer is the 7th most common cause of cancer death in the UK. Early detection of oesophageal cancer is low and five-year survival rates are around 15% due to the high proportion of patients presenting with metastatic
Immunotherapy for Oesophageal Cancer Read More »
The Prostate Is A Small Walnut Shaped Gland Which Sits Under The Bladder In A Man, And Its Main Function Is To Produce Semen. Around 47,000 men are diagnosed with Prostate Cancer each year in the UK and approximately 11,000 will die from the disease every year. The most common Prostate Cancers are a type
Identifying and treating advanced prostate cancer Read More »
